MRI, Efficacy, and Safety of Tolebrutinib in Highly Active Disease: 2-Year Data from Phase 2b Long-term Safety Study

被引：0
|
作者：
Fox, R. [1 ]
Oh, J. [2 ]
Arnold, D. [3 ]
Syed, S. [4 ]
Xu, Z. [5 ]
Turner, T. [4 ]
Traboulsee, A. [6 ]
Reich, D. [7 ]
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH USA
[2] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[3] McGill Univ, NeuroRx Res & Montreal Neurol Inst, Montreal, PQ, Canada
[4] Sanofi, Cambridge, MA USA
[5] Sanofi, Bridgewater, MA USA
[6] Univ British Columbia, Vancouver, BC, Canada
[7] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-318
引用
收藏
页码：526 / 527
页数：2
相关论文
共 50 条
  • [21] Treatment of gastric varices with 2-octyl-cyanoacrylate glue injection: A long-term (2-year) efficacy and safety study
    Chen, AM
    Binmoeller, KF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S349 - S350
  • [22] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Chen, L.
    Duan, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 261
  • [23] Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study
    Muenzer, Joseph
    Burton, Barbara K.
    Harmatz, Paul
    Gonzalez Gutierrez-Solana, Luis
    Ruiz-Garcia, Matilde
    Jones, Simon A.
    Guffon, Nathalie
    Inbar-Feigenberg, Michal
    Bratkovic, Drago
    Li, Xiaoxi
    Yee, Karen S.
    Alexanderian, David
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S73 - S74
  • [24] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
    Haibel, H.
    Brandt, H. C.
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Braun, J.
    Kupper, H.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
  • [25] MRI, Safety, and Efficacy Outcomes in Patients with Relapsing MS: 18-month Results from the Long-term Extension Study of Tolebrutinib
    Oh, J.
    Fox, R.
    Arnold, D. L.
    Syed, S.
    Orogun, L.
    Dukovic, D.
    Turner, T.
    Traboulsee, A.
    Reich, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 66 - 67
  • [26] Efficacy and safety of the 1,4-dihydropyridine calcium antagonist, barnidipine in the long-term (2-year)
    Smilde, JG
    Lustermans, FAT
    Erwteman, TM
    Klomps, HC
    Holwerda, NJ
    Hart, W
    JOURNAL OF HYPERTENSION, 2000, 18 : S56 - S56
  • [27] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [28] Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
    Megna, Matteo
    Ruggiero, Angelo
    Battista, Teresa
    Marano, Laura
    Cacciapuoti, Sara
    Potestio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [29] Efficacy and safety of acarbose in the treatment of Type 2 diabetes: data from a 2-year surveillance study
    Mertes, G
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 (01) : 63 - 70
  • [30] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
12345